{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:24:00Z","timestamp":1787109840911,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":6684,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1157\/13120038","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T11:31:26Z","timestamp":1209555086000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toxicidad de f\u00e1rmacos antirretrovirales en ni\u00f1os infectados por el virus de la inmunodeficiencia humana"],"prefix":"10.1016","volume":"68","author":[{"given":"E.","family":"N\u00fa\u00f1ez Cuadros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.aJ.","family":"Mellado Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rivera Cuello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Penim Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pi\u00f1eiro P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00eda-Hortelano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.aJ.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Villota Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00edn-Fontelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1157\/13120038_bb0005","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"Impact of introduction of protease inhibitor therapy on reductions in mortality among children and youth infected with HIV-1","volume":"345","author":"Gortmaker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13120038_bb0010","first-page":"863","article-title":"Impact of HAART on the survival and disease progression in HIV-1 infected children","volume":"22","author":"S\u00e1nchez-Granados","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13120038_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1157\/13070178","article-title":"Eficacia de la terapia antirretroviral en ni\u00f1os con infecci\u00f3n por VIH. Un corte transversal","volume":"62","author":"Gonz\u00e1lez-Tom\u00e9","year":"2005","journal-title":"An Esp Pediatr"},{"key":"10.1157\/13120038_bb0020","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200409030-00004","article-title":"Metabolic complications of HIV therapy in children","volume":"18","author":"McComsey","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13120038_bb0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1210\/jc.2003-030767","article-title":"Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children","volume":"89","author":"Mora","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13120038_bb0030","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidemia in HIV-infected children in Europe","volume":"18","author":"European Pediatric Lipodystrophy Group","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13120038_bb0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.qai.0000139397.30612.96","article-title":"Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C","volume":"38","author":"Farley","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13120038_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13120038_bb0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1157\/13099580","article-title":"Antiretroviral therapy and mitochondrial toxicity","volume":"128","author":"Santos","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13120038_bb0050","first-page":"249","article-title":"Alteraciones en la mineralizaci\u00f3n \u00f3sea en ni\u00f1os con infecci\u00f3n VIH tratados con TARGA","volume":"60","author":"Rojo","year":"2004","journal-title":"An Esp Pediatr"},{"key":"10.1157\/13120038_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1210\/jc.2004-0125","article-title":"Insulin sensitivity and beta-cell function in protease inhibitor- treated and naive human immunodeficiency virus-infected children","volume":"90","author":"Bitnun","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13120038_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1157\/13120038_bb0065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.aids.0000222074.45372.00","article-title":"Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy","volume":"20","author":"Crane","year":"2006","journal-title":"AIDS"},{"key":"10.1157\/13120038_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jinf.2001.0928","article-title":"Iatrogenic cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enchanced PI containing regimen","volume":"44","author":"Clevenbergh","year":"2002","journal-title":"J Infect"},{"key":"10.1157\/13120038_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006454-200301000-00018","article-title":"Metabolic complications of antiretroviral therapy in children","volume":"22","author":"Leonard","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13120038_bb0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","article-title":"Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children","volume":"32","author":"Vigano","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13120038_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.ijo.0802176","article-title":"Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV-infected children with lipohypertrophy","volume":"27","author":"Beregszaszi","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1157\/13120038_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1210\/jc.2003-031942","article-title":"Metabolic bone disease in human immunodeficiency virus-infected children","volume":"89","author":"Arpadi","year":"2004","journal-title":"J Clin Metab"},{"key":"10.1157\/13120038_bb0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","article-title":"Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children","volume":"32","author":"Vigano","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13120038_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","article-title":"Detection of lypoatrophy in human immunodeficiency-virus infected children treated with Highly active antiretroviral therapy","volume":"25","author":"Hartman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13120038_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/aid.2006.0039","article-title":"Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy. Res","author":"Chiane","year":"2007","journal-title":"Hum Retroviruses"},{"key":"10.1157\/13120038_bb0110","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000018744.58460.62","article-title":"Ezetimibe study group efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercolesterolemia","volume":"105","author":"Gagn\u00e9","year":"2002","journal-title":"Circulation"},{"key":"10.1157\/13120038_bb0115","first-page":"2159","article-title":"Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins","volume":"20","author":"Negredo","year":"2006","journal-title":"AIDS"},{"key":"10.1157\/13120038_bb0120","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2005.11.072","article-title":"Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia","volume":"47","author":"McKenney","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1157\/13120038_bb0125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00002030-200304110-00010","article-title":"Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART","volume":"17","author":"Calza","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13120038_bb0130","first-page":"e1","article-title":"A vascular necrosis of the hip (Leggs-Calve-Perthes disease) in HIV-infected children in longterm follow-up: PACTG Study 219","author":"Gaughan","year":"2002","journal-title":"Pediatrics"},{"key":"10.1157\/13120038_bb0135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/135965350501000304","article-title":"Incidence and risk factors for mitochondrial toxicity in treated HIV\/HCV-coinfected patients","volume":"10","author":"Laguno","year":"2005","journal-title":"Antivir Ther (London)"},{"key":"10.1157\/13120038_bb0140","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1345\/aph.1A444","article-title":"Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors","volume":"37","author":"Temple","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1157\/13120038_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.qai.0000143599.64234.15","article-title":"Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine","volume":"38","author":"Shlay","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13120038_bb0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/339486","article-title":"Indinavir-associated intersticial nephritis and urothelial inflammation: Clinical and cytologic findings","volume":"34","author":"Kopp","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13120038_bb0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-200104130-00021","article-title":"Indinavir and systemic hypertension","volume":"15","author":"Cattelan","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13120038_bb0160","unstructured":"HIV drug-drug interactious hivguidlines.org. \u00daltima revisi\u00f3n: 6\/2004."},{"key":"10.1157\/13120038_bb0165","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","article-title":"Iatrogenic cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus infected patients receining inhaled corticosteroids and ritonavir-boosred protease inhibitors: Six cases","volume":"90","author":"Samara","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13120038_bb0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00126334-200207010-00004","article-title":"Hyperlipidemia in HIV-infected children treated with protease inhibitors: Relevance for cardiovascular disease","volume":"30","author":"Cheseaux","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13120038_bb0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/01.inf.0000130073.48745.a6","article-title":"Effect of highly active antiretroviral therapy on cardiovascular involvement in children with human immunodeficiency virus infection","volume":"23","author":"Plebani","year":"2004","journal-title":"Pediatr Infec Dis J"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403308701760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403308701760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:25:05Z","timestamp":1787106305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403308701760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1695403308701760"],"URL":"https:\/\/doi.org\/10.1157\/13120038","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicidad de f\u00e1rmacos antirretrovirales en ni\u00f1os infectados por el virus de la inmunodeficiencia humana","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1157\/13120038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}